HeartSciences Inc.
HSCS
$2.05
-$0.02-0.97%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -2.27% | -- | -40.82% | -66.13% | -76.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.27% | -- | -40.82% | -66.13% | -76.34% |
| Cost of Revenue | -5.26% | -- | -19.57% | -55.74% | -68.85% |
| Gross Profit | 0.00% | -- | -50.50% | -71.20% | -80.00% |
| SG&A Expenses | 40.50% | 18.41% | 30.36% | 13.36% | 15.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.72% | -6.09% | 10.26% | 15.39% | 32.14% |
| Operating Income | -0.72% | 6.20% | -10.36% | -15.60% | -32.46% |
| Income Before Tax | -4.30% | 0.37% | -18.52% | -20.28% | -32.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.30% | 0.37% | -18.52% | -20.28% | -32.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.30% | 0.37% | -18.52% | -20.28% | -32.70% |
| EBIT | -0.72% | 6.20% | -10.36% | -15.60% | -32.46% |
| EBITDA | -0.84% | 6.10% | -10.54% | -15.67% | -32.45% |
| EPS Basic | 58.40% | 51.45% | 35.32% | 65.67% | 73.03% |
| Normalized Basic EPS | 58.40% | 51.45% | 35.31% | 65.66% | 73.03% |
| EPS Diluted | 58.40% | 51.45% | 35.32% | 65.67% | 73.03% |
| Normalized Diluted EPS | 58.40% | 51.45% | 35.31% | 65.66% | 73.03% |
| Average Basic Shares Outstanding | 176.86% | 149.48% | 112.17% | 105.00% | 165.65% |
| Average Diluted Shares Outstanding | 176.86% | 149.48% | 112.17% | 105.00% | 165.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |